ArticleClinical pharmacology and therapeutics2026
Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.
Yue Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.